Kaynaklar
1.Proposed diagnostic criteria and nosology of acute transverse myelitis. Transverse Myelitis Consortium Working Group. Neurology 2002;59:499–505.2. Rust R, Menkes JH: Autoimmune and postinfectious diseases. Menkes JH, Sarnat HB(eds): Child Neurology 6th Ed, Lippincott Williams & Wilkins 2000, 627-691.3. Connolly AM, Iannaccone ST:Anterior horn cell and cranial motor neuron disaese. Swaiman KF, Ashwal S, Ferriero DM(eds): Pediatric Neurology Principles & Practice. 4th Ed., Mosby Elsevier, Philadelphia, 2006,1859- 1886.4. Lahat E, Pillar G, Ravid S, Barzilai A, Etzioni A, Shahar E: Rapid recovery from transverse myelopathy in children treated with methylprednisolone. PediatrNeurol. 1998 ;19(4):279- 282.5. Defresne P, Meyer L, Tardieu M, Scalais E, Nuttin C, De Bont B, Loftus G, Landrieu P, Kadhim H, Sebire G: Efficacy of high dose steroid therapy in children with severe acute transverse myelitis. J Neurol Neurosurg Psychiatry. 2001 ;71(2): 272- 274.6. Sebire G, Hollenberg H, Meyer L, Huault G, Landrieu P, Tardieu M. High dose methylprednisolone in severe acute transverse myelopathy. Arch Dis Child.1997; 76(2):167- 168.7. Defresne P, Hollenberg H, Husson B, Tabarki B, Landrieu P, Huault G, Tardieu M, Sebire G: Acute transverse myelitis in children: clinical course and prognostic factors. J Child Neurol. 2003; 18 (6): 401-406.8. Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology 1999; 53:1107–1114.9. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006; 66:1485-1489.10.Dean M Wingerchuk, Vanda A Lennon, Claudia F Lucchinetti, Sean J Pittock, Brian G Weinshenker The spectrum of neuromyelitis optica. Lancet Neurol2007; 6: 805–15.11.Marcelo Matielloa, Anu Jacoba, Dean M. Wingerchukb and Brian G. Weinshenkera Neuromyelitis optica. Curr Opin Neurol 2007;20:255–260.
